9SGH
Bimekizumab Fab in complex with human interleukin-17A
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SLS BEAMLINE X10SA |
| Synchrotron site | SLS |
| Beamline | X10SA |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2023-09-01 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.99989 |
| Spacegroup name | P 21 21 2 |
| Unit cell lengths | 117.562, 148.492, 92.755 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 47.090 - 2.661 |
| R-factor | 0.2228 |
| Rwork | 0.221 |
| R-free | 0.25310 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.007 |
| RMSD bond angle | 0.930 |
| Data reduction software | autoPROC (1.1.7 (20230726)) |
| Data scaling software | autoPROC (1.1.7 (20230726)) |
| Phasing software | PHASER |
| Refinement software | BUSTER (2.11.8 (26-JUL-2023)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 92.755 | 2.918 |
| High resolution limit [Å] | 2.661 | 2.661 |
| Rmerge | 0.277 | 2.291 |
| Rmeas | 0.291 | 2.380 |
| Rpim | 0.086 | 0.640 |
| Number of reflections | 33970 | 1698 |
| <I/σ(I)> | 5.8 | 1.4 |
| Completeness [%] | 93.9 | 58.8 |
| Redundancy | 10.6 | 13.1 |
| CC(1/2) | 0.998 | 0.626 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 292 | 0.2M zinc acetate, 0.1M imidazole pH 6.5, 10% PEG 8,000 |






